CB
Caitlin Mattos Briggs
  • Vaccine Development, Arbovax Inc., USA
研究方向
  • Immunology
Chikungunya ELISA Protocol
酶联免疫吸附法(ELISA)测定基孔肯雅病毒
作者:Caitlin Mattos Briggs, Amanda Piper and Raquel Hernandez日期:02/20/2014,浏览量:9726,Q&A: 0
This protocol will result in the accurate qualitative measurement of anti-Chikungunya virus antibody (Ab) from infected mouse tissue or serum. This assay was developed by Dr. Caitlin Briggs, Arbovax, Inc. Chikungunya is a BL3 agent and should be handled in a biosafety level 3 laboratory under BL3 conditions. This protocol was used in the publication “Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice” (Piper et al., 2013).